For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

CRISPR Treatment Shows Promise in Reducing LDL Cholesterol by 52% in Human Trial

Sep 7, 2026
CRISPR Treatment Shows Promise in Reducing LDL Cholesterol by 52% in Human Trial

In a significant development in metabolic health, researchers from the Cleveland Clinic have published findings from a clinical trial demonstrating that a one-time CRISPR treatment can effectively reduce levels of low-density lipoprotein (LDL) cholesterol by an average of 52%. This treatment, referred to as CTX310, utilizes a precise DNA-editing technology to induce a permanent genetic modification that lowers LDL cholesterol by targeting the liver protein ANGPTL3, which is known to play a role in cholesterol metabolism. The study, published in the New England Journal of Medicine, involved 15 participants with serious cholesterol-related health issues, who received an intravenous infusion of nanoparticles containing CRISPR instructions. Remarkably, the treatment was associated with minimal adverse events, and the beneficial effects on cholesterol levels persisted even after a year. Specifically, participants who received the highest dose saw ANGPTL3 levels drop by an average of 78.6 percent, alongside a 52.5 percent reduction in LDL cholesterol and a 47.8 percent decrease in triglycerides. While one participant did die during the study, researchers concluded that this was unrelated to the treatment. The findings suggest that CTX310 could represent a groundbreaking therapeutic opportunity for individuals with lipid disorders that do not respond to conventional therapies. However, the researchers caution that further trials are necessary to assess the long-term viability and safety of this approach, particularly as gene editing carries inherent risks. A phase 1b trial is currently underway to evaluate the efficacy of a fixed dose of CTX310 in various cohorts of patients with lipid disorders. This innovative treatment could potentially simplify management for patients, moving away from daily or weekly therapies to a one-time intervention that mimics natural genetic variations associated with lower cardiovascular risk. As the research progresses, it will be crucial to monitor the broader implications of such genetic interventions in metabolic health.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)